Cardiovascular risk in non-alcoholic fatty liver disease: mechanisms and therapeutic implications
New evidence suggests that non-alcoholic fatty liver disease (NAFLD) has a strong
multifaceted relationship with diabetes and metabolic syndrome, and is associated with …
multifaceted relationship with diabetes and metabolic syndrome, and is associated with …
ACG clinical guideline: disorders of the hepatic and mesenteric circulation
Disorders of the mesenteric, portal, and hepatic veins and mesenteric and hepatic arteries
have important clinical consequences and may lead to acute liver failure, chronic liver …
have important clinical consequences and may lead to acute liver failure, chronic liver …
[HTML][HTML] Global hemostatic profiling in patients with decompensated cirrhosis and bacterial infections
A Zanetto, E Campello, C Bulato, S Gavasso… - JHEP Reports, 2022 - Elsevier
Background & Aims Bacterial infections in cirrhosis are associated with increased bleeding
risk. To assess the factors responsible for bleeding tendency in patients with bacterial …
risk. To assess the factors responsible for bleeding tendency in patients with bacterial …
[HTML][HTML] Anticoagulation in the cirrhotic patient
In the past, patients with liver cirrhosis were thought to be prone to increased bleeding risk.
However, those with compensated liver cirrhosis actually have normal coagulative balance …
However, those with compensated liver cirrhosis actually have normal coagulative balance …
[HTML][HTML] Coagulation and endothelial dysfunction associated with NAFLD: current status and therapeutic implications
Non-alcoholic fatty liver disease (NAFLD) is closely related to insulin resistance, type 2
diabetes mellitus and obesity. It is considered a multisystem disease and there is a strong …
diabetes mellitus and obesity. It is considered a multisystem disease and there is a strong …
NASHFit: A randomized controlled trial of an exercise training program to reduce clotting risk in patients with NASH
JG Stine, IR Schreibman, AJ Faust, J Dahmus… - …, 2022 - Wiley Online Library
Background and Aims NASH is a common disease associated with increased rates of
thromboembolism (TE). Although exercise training can lessen thrombotic risk in patients with …
thromboembolism (TE). Although exercise training can lessen thrombotic risk in patients with …
Direct oral anticoagulants in patients with liver disease in the era of non-alcoholic fatty liver disease global epidemic: a narrative review
S Ballestri, M Capitelli, MC Fontana, D Arioli… - Advances in …, 2020 - Springer
Atrial fibrillation (AF) and venous thromboembolism (VTE) are highly prevalent and relevant
healthcare issues. Direct oral anticoagulants (DOACs) are now the first-choice for …
healthcare issues. Direct oral anticoagulants (DOACs) are now the first-choice for …
[HTML][HTML] Procedural-related bleeding in hospitalized patients with liver disease (PROC-BLeeD): An international, prospective, multicenter observational study
NM Intagliata, RS Rahimi, F Higuera-de-la-Tijera… - Gastroenterology, 2023 - Elsevier
Background & Aims Hospitalized patients with cirrhosis frequently undergo multiple
procedures. The risk of procedural-related bleeding remains unclear, and management is …
procedures. The risk of procedural-related bleeding remains unclear, and management is …
Haemostatic profiles are similar across all aetiologies of cirrhosis
S Bos, B van den Boom… - Thrombosis and …, 2019 - thieme-connect.com
Background and Aim Patients with cirrhosis may acquire profound changes in haemostasis.
Although haemostatic changes in cirrhosis have been extensively studied, most studies …
Although haemostatic changes in cirrhosis have been extensively studied, most studies …
Loss of hepatic PPARα in mice causes hypertension and cardiovascular disease
The leading cause of death in patients with nonalcoholic fatty liver disease (NAFLD) is
cardiovascular disease (CVD). However, the mechanisms are unknown. Mice deficient in …
cardiovascular disease (CVD). However, the mechanisms are unknown. Mice deficient in …